Literature DB >> 16515480

Selective androgen receptor modulators in drug discovery: medicinal chemistry and therapeutic potential.

Rodolfo Cadilla1, Philip Turnbull.   

Abstract

Modulation of the androgen receptor has the potential to be an effective treatment for hypogonadism, andropause, and associated conditions such as sarcopenia, osteoporosis, benign prostatic hyperplasia, and sexual dysfunction. Side effects associated with classical anabolic steroid treatments have driven the quest for drugs that demonstrate improved therapeutic profiles. Novel, non-steroidal compounds that show tissue selective activity and improved pharmacokinetic properties have been developed. This review provides an overview of current advances in the development of selective androgen receptor modulators (SARMs).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16515480     DOI: 10.2174/156802606776173456

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  14 in total

Review 1.  Ockham's razor and selective androgen receptor modulators (SARMs): are we overlooking the role of 5alpha-reductase?

Authors:  Wenqing Gao; James T Dalton
Journal:  Mol Interv       Date:  2007-02

2.  Analysis of selective androgen receptor modulators by gas chromatography-microchip atmospheric pressure photoionization-mass spectrometry.

Authors:  Laura Luosujärvi; Markus Haapala; Mario Thevis; Ville Saarela; Sami Franssila; Raimo A Ketola; Risto Kostiainen; Tapio Kotiaho
Journal:  J Am Soc Mass Spectrom       Date:  2009-11-06       Impact factor: 3.109

Review 3.  Muscle quality in aging: a multi-dimensional approach to muscle functioning with applications for treatment.

Authors:  Maren S Fragala; Anne M Kenny; George A Kuchel
Journal:  Sports Med       Date:  2015-05       Impact factor: 11.136

4.  Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women.

Authors:  Richard V Clark; Ann C Walker; Susan Andrews; Philip Turnbull; Jeffrey A Wald; Mindy H Magee
Journal:  Br J Clin Pharmacol       Date:  2017-06-10       Impact factor: 4.335

Review 5.  Sarcopenia - pathophysiology and clinical relevance.

Authors:  Michael Drey
Journal:  Wien Med Wochenschr       Date:  2011-07-29

Review 6.  Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs).

Authors:  Wenqing Gao; James T Dalton
Journal:  Drug Discov Today       Date:  2007-02-07       Impact factor: 7.851

7.  Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands.

Authors:  John David Norris; James David Joseph; Andrea Barreto Sherk; Dalia Juzumiene; Philip Stewart Turnbull; Stephen William Rafferty; Huaxia Cui; Erin Anderson; Daju Fan; Delita Arnelle Dye; Xiang Deng; Dmitri Kazmin; Ching-Yi Chang; Timothy Mark Willson; Donald Patrick McDonnell
Journal:  Chem Biol       Date:  2009-04-24

8.  RAISING AWARENESS ON THE URGENT NEED TO IMPLEMENT FRAILTY INTO CLINICAL PRACTICE.

Authors: 
Journal:  J Frailty Aging       Date:  2013-09

9.  Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations.

Authors:  B Vellas; M Pahor; T Manini; D Rooks; J M Guralnik; J Morley; S Studenski; W Evans; C Asbrand; R Fariello; S Pereira; Y Rolland; G Abellan van Kan; M Cesari; Wm C Chumlea; R Fielding
Journal:  J Nutr Health Aging       Date:  2013-07       Impact factor: 4.075

10.  Optimizing Ligand Efficiency of Selective Androgen Receptor Modulators (SARMs).

Authors:  Anthony L Handlon; Lee T Schaller; Lisa M Leesnitzer; Raymond V Merrihew; Chuck Poole; John C Ulrich; Joseph W Wilson; Rodolfo Cadilla; Philip Turnbull
Journal:  ACS Med Chem Lett       Date:  2015-11-19       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.